Upstream Bio, Inc. - COMMON STOCK (UPB)

CUSIP: 91678A107

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 5 signals
Share change
+39,613,174
SEC-reported price per share
$16.44
Indexed holders
70
Value change
+$649,643,232
Number of buys
66
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
54,984,855

Security key

91678A107

Report period

Q4 2024

Indexed institutions

70

Top holders

10

Ownership snapshot

Top reported holders of UPB - Upstream Bio, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AI Upstream LLC
Disclosed value leader
—
Comparable rows
0/3
Latest evidence
15 Oct 2024
3/4/5 Some rows are evidence-backed but not safely comparable across classes. 3 rows are not safely comparable across share classes.

Quick read

SEC ownership evidence is available, but the rows are not safely comparable across share classes.

0 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AI Upstream LLC's linked filing trail.
Detailed SEC evidence table Showing 1-3 of 3 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AI Upstream LLC
3/4/5
10%+ Owner
—
denominator unverified
—
5,494,410 shares
— 15 Oct 2024
ORBIMED ADVISORS LLC
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
4,554,873 shares
— 15 Oct 2024
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
3/4/5
10%+ Owner
—
denominator unverified
—
894,733 shares
— 15 Oct 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
70
Shares
42,074,592
Indexed holders
70
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2024 vs Q2 2026 Across Filers

Q2 2026 indexed holders
147
Q4 2024 indexed holders
70
Indexed holder difference
-77
Investor Q2 2026 Shares Q4 2024 Shares Share Diff Share Chg % Q2 2026 value Q4 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .